Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients
- PMID: 7397479
- DOI: 10.1093/brain/103.2.281
Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients
Abstract
The information of 349 cases of multiple sclerosis, seen in a neurological department over a twenty-year period and followed up for a mean of nine years, was analysed by computerized data processing. The mean age at onset was 30.0 years for the remittent onset types (82 per cent cases) and 37.3 years for the progressive onset types (18 per cent cases). During the course of the disease the age of the 'pure relapse' stage was 29.2 years, of the relapse with sequelae stage 33.9 years and of the progressive phase 38.0 years. The interval between the first two relapses in the remittent-progressive type was important, the shorter the interval the sooner the progressive phase occurred. The relapses tended to increase in frequency before the progressive phase started. Using an actuarial graph, 50 per cent of cases could be expected to be moderately disabled (still ambulatory) in six years, and severely disabled (not ambulatory) in eighteen years and dead in thirty years. Combining a disability score and the duration of the disease prognostic factors could be studied. A late onset of the disease, a short interval between the first two relapses and the occurrence of the progressive phase were associated with a poor outcome. Sex of patient, the symptomatology of the initial relapses, and the constituents of the CSF had no prognostic value.
Similar articles
-
Natural history of multiple sclerosis: a unifying concept.Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16. Brain. 2006. PMID: 16415308
-
Early prognostic factors for disability in multiple sclerosis, a European multicenter study.Acta Neurol Scand. 1992 Mar;85(3):212-8. doi: 10.1111/j.1600-0404.1992.tb04031.x. Acta Neurol Scand. 1992. PMID: 1575007 Clinical Trial.
-
Natural history of multiple sclerosis: risk factors and prognostic indicators.Curr Opin Neurol. 2007 Jun;20(3):269-74. doi: 10.1097/WCO.0b013e32812583ad. Curr Opin Neurol. 2007. PMID: 17495619 Review.
-
Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.Brain. 1990 Dec;113 ( Pt 6):1597-628. doi: 10.1093/brain/113.6.1597. Brain. 1990. PMID: 2276037
-
[Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].Nervenarzt. 1996 Jun;67(6):435-43. Nervenarzt. 1996. PMID: 8767197 Review. German.
Cited by
-
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis.Front Neurol. 2020 Sep 2;11:944. doi: 10.3389/fneur.2020.00944. eCollection 2020. Front Neurol. 2020. PMID: 32982947 Free PMC article.
-
Cost effectiveness analysis of Avonex and CinnoVex in Relapsing Remitting MS.Glob J Health Sci. 2014 Oct 9;7(2):139-47. doi: 10.5539/gjhs.v7n2p139. Glob J Health Sci. 2014. PMID: 25716386 Free PMC article.
-
[Dementia as a primary symptom in late onset multiple sclerosis. Case series and review of the literature].Nervenarzt. 2005 Jun;76(6):748-55. doi: 10.1007/s00115-004-1814-4. Nervenarzt. 2005. PMID: 15578150 Review. German.
-
Clinical characteristics of patients with late-onset multiple sclerosis.J Neurol. 2008 May;255(5):697-702. doi: 10.1007/s00415-008-0778-x. Epub 2008 Feb 19. J Neurol. 2008. PMID: 18283394
-
Is the frequency of multiple sclerosis increasing in Mexico?J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):528-30. doi: 10.1136/jnnp.59.5.528. J Neurol Neurosurg Psychiatry. 1995. PMID: 8530940 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical